Overview

Theripio Innovations is advancing transformative therapies for rare pediatric neurological disorders caused by single-gene mutations. Our lead program targets MEF2C Haploinsufficiency Syndrome, a lifelong disability that severely impacts a child’s ability to move, communicate, and learn. Our unique approach restores critical protein function directly within affected cells, allowing for treatments that are more precise, less invasive, and faster to reach patients than traditional strategies.